Micro Therapeutics, Inc.

Medlogic Global Corporation

Stackhouse, Inc.

Boston Scientific Scimed, Inc.

Other

Covidien LP

Flowers Park Ltd.

Sub-q, Incorporated

Enteric Medical Technologies, Inc.

Intersect Partners, LLC

Richard J Greff

George B Wallace

Michael M Byram

Scott M Evans

Michael L Jones

Ian N Askill

Andrew H Cragg

Leonard V Barley, Jr

Thomas J Whalen

Blair D Walker

John Perl

Patrick J Tighe

George Robert Greene

Earl Slee

Noah M Roth

James I Wright

Chinh Ngoc Tran

John Perl, Ii

Robert A Pecor

Douglas Ray Hayman

Connie C Lee

Ronald E Thomas, Jr

Donald R Reiterman

Bart Lewis Dolmatch

Robert Goebel

Richard T VanRyne

Charlie Ricci

Mark Philip Ashby

Todd J Hewitt

Ed Olson

Ed F Nicolas

Kevin P Gilmartin

Mark A Pecor

Steven E Holian

David W Tung

Eduardo C Sing

Hosheng Tu

Jonathan Kagan

Alan A Stein

David E Silverman

Rodolfo C Quijano

Frederic S Bongard

Mildred K Stackhouse

Wyman H Stackhouse

Stanley R Klein

Martin J Green

Bruce McLucas

Jacques Moret

Carlos Roberto Morales

Thomas Jay Berger

Robert J Socci, Jr

A liquid embolic delivery system is provided for trapping an injected liquid embolic composition to prevent the liquid embolic from solidifying or otherwise passing outside of an embolization area. The delivery system includes a catheter for delivery of a liquid embolic composition and a containment member positioned at a distal end of the catheter which is shaped to trap the liquid embolic composition delivered through the lumen of the catheter. The containment member is formed as a brush, nest, sponge, swab, flexible sack, or other shape into and around which the liquid embolic composition is injected. The liquid embolic composition is trapped or meshes with the containment member during solidification containing the liquid embolic and preventing the embolic composition from passing into the blood stream.

Device and method for controlling injection of liquid embolic composition

Disclosed is a biocompatible, hemostatic, cross-linked gelatin composition comprising a biocompatible material comprising cross-linked gelatin and a sufficient amount of wetting agent to permit uniform wetting of the sponge in the presence of an aqueous solution.

Cross-linked gelatin composition comprising a wetting agent

Cross-linked gelatin composition coated with a wetting agent

A medical device and methods to relieve joint pain and adapted for knee joint repair, replacement and augmentation. The invention discloses joint lubricant, particularly hyaluronate compositions and methods for treatment of osteoarthritis.

Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis

Disclosed are novel compositions for embolizing blood vessels which are particularly suited for treating vascular lesions via catheter delivery.

High viscosity embolizing compositions

Disclosed are novel high viscosity compositions for embolizing blood vessels which comprise a biocompatible prepolymer and a contrast agent, and optionally a thickening agent and/or a biocompatible solvent. Also disclosed are methods for embolizing a vascular site by injecting high viscosity prepolymer compositions into said site. The disclosed compositions and methods are particularly well suited for the treatment of aneurysms.

High viscosity embolizing compositions comprising prepolymers

Disclosed are methods for sterilizing cross-linked gelatin as well as to sterilized cross-linked gelatin. In particular, the methods of this invention employ E-beam sterilization techniques.

Methods for sterilizing cross-linked gelatin compositions

Disclosed are novel radioactive compositions which are particularly suited for treating solid mass tumors via catheter delivery.

Radioactive embolizing compositions

Disclosed are compositions suitable for use in embolizing blood vessels which compositions comprise a polymer, a biocompatible solvent and a contrast agent. The polymer is selected from the group consisting of polyacrylonitrile, polyurethane, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and copolymers of urethane/carbonate and copolymers of styrene/maleic acid.

Compositions for use in embolizing blood vessels

This invention is directed to methods for treating aneurysms wherein the aneurysmal sac is filled with a non-particulate agent or plurality of such agents and/or with a fluid composition which solidifies in situ. Filling of the aneurysmal sac employs sufficient amount of the non-particulate agent or plurality of such agents and/or the fluid composition to inhibit blood flow into the aneurysm sac. In addition, the methods of this invention also provide for non-endogenous isolation of the parent artery proximal and distal to the aneurysmal sac from systemic blood flow of the treated mammal. The combination of these features provides for treatment of the aneurysmal sac while, at the same time, inhibiting aneurysm formation and/or regrowth in the diseased portions of the arterial wall proximal and distal to the treated aneurysm.

Methods for treating aneurysms

Disclosed are methods for treating urinary incontinence in a mammal wherein a composition comprising a biocompatible polymer, a biocompatible solvent, and a contrast agent is delivered to the periurethral tissue of the mammal.

Kit of parts for treating urinary incontinence in mammals

Disclosed are methods for vascular reconstruction of diseased, non-aneurysmal arteries.

Methods for vascular reconstruction of diseased arteries

Growing community of inventors

St. Pete Beach, FL, United States of America

Richard J Greff